iPhone | iPad
Android
HuaweiPartner Content By KT Engage
Mediclinic Middle East announces partnership with dnata Travel Management
Agreement will ensure seamless travel service solutions for all international visitors seeking medical treatment in the UAE.
Mediclinic has signed a strategic partnership agreement with dnata Travel Management, part of the dnata Travel Group, to provide seamless travel service solutions for all international visitors seeking medical treatment in the UAE.
Teams from both companies, including Mr. Ahmed Ali, Executive Director of Mediclinic Middle East, and Mr. Savio Vaz, Vice President - Government & Corporate Travel, dnata Travel Group, attended the agreement signing ceremony which took place at Mediclinic Dubai Mall.
The agreement also includes travel management services for Mediclinic Middle East employees, who can benefit from the unique products and services offered by dnata Travel Management.
Ahmed Ali, Executive Director of Mediclinic Middle East, said: "With a broad range of preventative and therapeutic healthcare services provided at JCI-accredited facilities by internationally qualified and experienced doctors, Mediclinic Middle East is committed to supporting the UAE Government’s focus on increasing healthcare tourism into the UAE. This partnership with dnata ensures that patients can expect a complete world-class service, not only for their medical treatment, but for their entire travel planning."
Savio Vaz, Vice President - Government & Corporate Travel at dnata Travel Group, said: "We are delighted to be partnering with Mediclinic Middle East to assist their international patients and employees with their travel arrangements, by providing a true one stop travel solution to complement Mediclinic's service offering. With dnata Travel Management and Mediclinic both being trusted brands in the market, it made perfect sense for us to expand on our existing partnership to drive additional value for both organisations and our customers."
Mediclinic Middle East is part of Mediclinic International plc, a London Stock Exchange (LSE)-listed private healthcare group with three operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates. Mediclinic International also holds a 29.9% interest in Spire Healthcare Group plc, a LSE-listed and UK-based private healthcare group.
The foundation of Mediclinic lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment.
Mediclinic Middle East operates seven hospitals and more than 20 clinics in the UAE with over 900 inpatient beds.